Option Care Health, Inc. (OPCH)

NASDAQ: OPCH · IEX Real-Time Price · USD
33.54
+0.36 (1.08%)
At close: Mar 28, 2024, 4:00 PM
33.20
-0.34 (-1.01%)
After-hours: Mar 28, 2024, 5:48 PM EDT

Company Description

Option Care Health, Inc. offers home and alternate site infusion services in the United States.

The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.

It also offers treatments to manage the progression of neurological disorders, such as multiple sclerosis, duchenne muscular dystrophy, and other neurological disorder; infusion therapies for bleeding disorders, such as hemophilia and von Willebrand diseases; therapies for women with high-risk pregnancies; and other infusion therapies to treat various conditions, including pain management, chemotherapy, and respiratory medications, as well as nursing services.

The company markets its services through patient referrals, including physicians, hospital discharge planners, hospital personnel, health maintenance organizations, and preferred provider organizations.

Option Care Health, Inc. is headquartered in Bannockburn, Illinois.

Option Care Health, Inc.
Option Care Health logo
Country United States
Industry Medical Care Facilities
Sector Healthcare
Employees 7,802
CEO John C. Rademacher

Contact Details

Address:
3000 Lakeside Dr, Suite 300n
Bannockburn, Illinois 60015
United States
Phone 312 940 2443
Website optioncarehealth.com

Stock Details

Ticker Symbol OPCH
Exchange NASDAQ
Fiscal Year January - December
Reporting Currency USD
CIK Code 0001014739
CUSIP Number 68404L201
ISIN Number US68404L2016
Employer ID 05-0489664
SIC Code 8082

Key Executives

Name Position
John C. Rademacher Chief Executive Officer, President and Director
Michael H. Shapiro Chief Financial Officer and Senior Vice President
Collin G. Smyser General Counsel and Corporate Secretary
Richard P. Denness Non-Executive Employee
Luke Whitworth Chief Operating Officer
Brett Michalak Chief Information Officer
Caroline Budde Senior Vice President and Chief Compliance Officer
Michael Bavaro Chief Human Resources and Diversity Officer
Julie Koenig Senior Vice President of Operations
Cari Reed Senior Vice President of Quality and Clinical Services

Latest SEC Filings

Date Type Title
Mar 14, 2024 8-K Current Report
Feb 28, 2024 144 Filing
Feb 22, 2024 10-K Annual Report
Feb 22, 2024 8-K Current Report
Feb 13, 2024 SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals
Jan 23, 2024 SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals
Dec 29, 2023 8-K Current Report
Dec 11, 2023 8-K Current Report
Oct 25, 2023 10-Q Quarterly Report
Oct 25, 2023 8-K Current Report